K172312

Substantially Equivalent

eego amplifiers

Applicant: Eemagine Medical Imaging Solutions GmbH
Product code: GWL
Advisory panel: Neurology
Date received: 2017-08-01
Decision date: 2018-03-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Berlin, DE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.